Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cancer Drugs: US FDA Looks Outside For Help On Generic Labeling Updates

Executive Summary

Under the Oncology Center of Excellence’s Project Renewal, agency has contracted with consulting firm Deloitte to establish subject matter expert research teams that will review published literature on off-patent drugs and suggest labeling updates.


Advertisement

Related Content

Generic Labeling Problems Targeted In US FDA Budget Request
Generic Labeling Problems Targeted In US FDA Budget Request
Cancer Drugs: US FDA Looks Outside For Help On Generic Labeling Updates
Cancer Drugs: US FDA Looks Outside For Help On Generic Labeling Updates
Opioids, Old Initiatives Dominate FY 2020 US FDA Funding Increase
US FDA Wins Big In Shutdown-Averting Approps Bill
Project Renewal: US FDA's Plan To Update Generic Cancer Drug Labels Depends On NDA Holders
US FDA's Label Updating Effort Needs Legislation To Impact Generics
US FDA Looks To Proactively Update Old Generic Drug Labels Under Pilot
Labeling Updates For Old Drugs Could Be Faster Under Streamlining Proposal

Topics

Advertisement
UsernamePublicRestriction

Register

PS125059

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel